• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Study to determine if pesticides disrupt endocrine systems

April 17, 2009

Washington -- The Environmental Protection Agency (EPA) is ordering the manufacturers of 67 pesticide chemicals to test whether their chemicals disrupt the endocrine systems in animals and humans.

Washington

-- The Environmental Protection Agency (EPA) is ordering the manufacturers of 67 pesticide chemicals to test whether their chemicals disrupt the endocrine systems in animals and humans.

Endocrine disruptors are chemicals that interact with and possibly disrupt the hormones produced or secreted by the animal or human endocrine system, which regulates growth, metabolism and reproduction.

"Endocrine disruptors can cause lifelong health problems -- especially for children," said EPA Administrator Lisa P. Jackson. "Gathering this information will help us work with communities and industry to protect Americans from harmful exposure."

The EPA will issue test orders to the manufacturers this summer to determine whether their chemicals disrupt estrogen, androgen and thyroid.

Advertisement

The list of chemicals the EPA has ordered tested was developed on the basis of exposure potential and should not be construed as a list of known or likely endocrine disruptors, the agency cautions.

The listed pesticide chemicals were selected because there is high potential for exposure through food and water, human residential activity or agricultural pesticide application.

Testing, conducted through the Endocrine Disruptor Screening Program (EDSP), eventually will be expanded to cover all pesticide chemicals.

Related Content:

RegulatoryBreaking News
USDA aims to strengthen handling regulations for exotic animals in exhibition
USDA aims to strengthen handling regulations for exotic animals in exhibition
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement